Berkeley, CA · Founded 2019 · Privately Held (backing)
Developer of antibiotic therapies designed to treat pathogen-driven diseases. FlightPath (Drug Discovery) is based in Berkeley, CA and was founded in 2019. Its last known valuation is $21 million. It has raised $9.7 million.
Last price · $/share
—
Implied valuation
$21.0M
Total raised
$9.7M
Last round
—
Cap table — not yet on record
FlightPath (Drug Discovery)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of FlightPath (Drug Discovery) with a free Private Market View account
·Watch FlightPath (Drug Discovery): the Monday email on marks, rounds and moves
